1Antzelevitch C, Sicouri S, Litovsky SH, et al. Heterogeneity within the ventricular wall. Electrophysiology and pharmacology of epicardial,endocardial and M cells. Circ Res, 1991,69:1427-1449.
2Antzelevitch C,Sioouris S. Dtug-induced afterdepolarizations and triggered activity occur in a discrete subpopulation of ventricular muscle cells(M cells)in the canine heart:quinidine and digitalis.J Cardiovasc Electrophysiol,1993,4:48-58.
3Antzelevitch C, Sicouris S. Clinical relevance of cardiac arrhythmias generated by afterdepolarizations. Role of M cells in the generation of U waves, triggered activity and torsadede pointes. J Am Coll Cardiol, 1994,23 : 259-277.
4Haverkamp W, Martinez-Rubio A, Hief C, et al. Efficacy and safety of d,l-sotalol,in patients with ventricular tachycardia and in survivors of cardiac arrest. J Am Coil Cardiol, 1997,30: 487-495.
5Verduyn S, Vos MA, van der Zande J, et al. Further observations to elucidate the role of interventricular dispersion of repolarization and early afterdepolarization in the genesis of acquired torsade de pointes arrhythmias: a comparison between almokalant and d-sotalol using the dog as its own control. J Am Coll Cardiol, 1997,15 : 1575-1584.
6Antzelevitch C,Stm ZQ, Zhang ZQ, et al. Cellular and ionic mechanisnas underlying erythromydn-induced long QT intervals and torsade de pointes. J Am Coll Cardiol, 1996,28:1836-1848.
7Hohnloser SH, Klingenheben T, Singh BN, et al. Amiodarone-associated proarrhythmic effects. A review with special reference to torsade de-pointes tachycardia. Ann Intern Med,1994,121:529-535.
8Sicouri S,Moro S,Litovsky S,et al. Chronic amiodarone reduces transrnural dispersion of repolarization in the canine heart. J Cardiovase Electrophysiol, 1997,8 : 1269-1279.
9Viskin S, Alla SR, Barron HV, et al. Mode of onset of torsade de pointes in congenital long QT syndrome. J Am Coll Cardiol, 1996, 28: 1262-1268.
10Vos MA, Gorenek B, Verduyn SC, et al. Observations on the onset of Torsade de Pointes arrhythmias in the acquired long QT syndrome. Cardiovasc Res, 2000, 48: 421-429.
8Gupta A, Lawrence AT, Krishnan K, et al. Current concepts in the mechanisms and managements of drug-induced QT prolongation and tor- sade de points. Am Heart J,2007,153:89.
9Yap AG, Camm AJ. Drug induced QT prolongation and torsades de pointes. Heart ,2003,89 : 1363-1372.
